ARS Pharmaceuticals是一家专注于开发新型治疗过敏药物的生物技术公司。其旗舰产品Neffy是一种吸收增强型肾上腺素鼻喷雾剂,具有给药快速、携带方便等优势,有望成为替代肾上腺素注射的新型治疗方式。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.